Threat Intelligence Brief
Curated summary with source attribution
Source: biospace.com
Threat Risk: Medium
Victim: Amgen / Pharmaceutical Sector
Incident: Unauthorized exfiltration of proprietary and patient health information from cloud repositories.
Impact: Exposure of sensitive patient data and proprietary corporate information.
Attacker: Unidentified threat actors
Analysis: The breach occurred via unauthorized access to cloud storage managed by third-party providers. While operational stability remains intact, the volume and sensitivity of exfiltrated data led the company to classify the event as material. This incident highlights a recurring trend of threat actors targeting high-value pharmaceutical data.
Recommendations: Audit third-party cloud storage permissions and access logs regularly.; Implement robust encryption for sensitive patient health information at rest.; Strengthen vendor risk management and third-party security oversight.
Source: BioSpace
Editorial note: this post summarizes third-party reporting and links to the original source.
View Original Source